Where does it hurt?
Choose a procedure:
By choosing "Find a Doctor" acknowledge that I've reviewed and agree to the website's privacy policy .
Where does it hurt?
Choose a procedure:
By choosing "Find a Doctor" acknowledge that I've reviewed and agree to the website's privacy policy .
Start the conversation now.
If hip or knee pain is making you live life on pause, it may be time to talk with a doctor about treatment options. Because life is a lot more fun when you Hit Play!
We are inspired by the opportunity to work together to advance patient care.
Johnson & Johnson Medical Devices Companies (JJMDC) advance patient care while delivering clinical and economic value to healthcare systems and helps providers address individual needs through a holistic approach.
Where does it hurt?
Choose a procedure:
By choosing "Find a Doctor" acknowledge that I've reviewed and agree to the website's privacy policy .
Find a Doctor
This site is published by the Companies, which are solely responsible for its content.
This site is for visitors from the United States.
Follow UsHealthcare Professionals
Hospital Providers
Ambulatory Surgery Centers
Careers - Johnson & Johnson
About Toggle navigation
(Craniomaxillofacial)
Joint Reconstruction (Knee, Hip & Shoulder)
Mitek Sports Medicine
What We Believe
Principles of Collaboration
Exhibits and Commercial Sponsorships
Investigator Initiated Research
About Sysnthes Hero Image
The Companies
Johnson & Johnson Family of Companies
We offer the world’s most comprehensive portfolio of orthopaedic and neuro and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials.
Joint Reconstruction
One of the largest orthopaedics companies in the world, with leading solutions for hip, knee and shoulder replacement.
The global leader in orthopaedic trauma devices for internal and external fixation.
Offering one of the world’s most diverse portfolios of spinal-care solutions for both traditional and minimally invasive spine surgery.
Mitek Sports Medicine
leading developer and manufacturer of pain management and minimally invasive solutions, including sports medicine and soft-tissue repair products.
Delivering a comprehensive range of power instrument systems, reamers and saws to meet a broad spectrum of clinical needs.
Providing a wide range of solutions for the diagnosis and treatment of neurological disorders focusing on neurovascular, neurosurgery and neuromodulation solutions.
Offering systems that provide a complete array of implants and instruments for the treatment of facial trauma, tumor resection and reconstruction.
Careers - Johnson & Johnson 
Consultant Identification & Payments
©2014-2018. All rights reserved. This site is published by Companies which is solely responsible for its content. This site is intended for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.
×Healthcare Professionals
Hospital Providers
Ambulatory Surgery Centers
Careers - Johnson & Johnson
(Craniomaxillofacial)
Joint Reconstruction (Knee, Hip & Shoulder)
Mitek Sports Medicine
What We Believe
Principles of Collaboration
Exhibits and Commercial Sponsorships
Investigator Initiated Research
Announces Agreement with Ortho Development® Corporation to Promote its KASM® Knee Articulating Spacer Mold 
16, 2018 Warsaw, – Johnson & Johnson Medical Devices Companies* today announced that Sales, Inc. has entered into an exclusive agreement with Ortho Development® Corporation to co-promote in the its KASM® Knee Articulating Spacer Mold. This is a sterile, disposable cement spacer mold for patients who develop an infection after primary knee replacement. This new offering builds upon Synthes’** commitment to innovative knee solutions focused on helping patients along the care continuum.
Expands Spine Portfolio with Nerve Assessment Platform  Designed to Identify & Avoid Nerves During Spine Surgery 
Los Angeles – September 26, 2018 – Johnson & Johnson Medical Devices Companies* announced today that Synthes** is introducing MMG, a first-of-its-kind digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery. enables motor nerve monitoring for a variety of spine procedures, including non-fusion procedures such as discectomy and both minimally invasive (MIS) and open spinal fusion surgery.  is being broadly introduced at the 2018 North America Spine Society Meeting in Los Angeles, California. 
Johnson & Johnson Medical GmbAcquires Emerging Implant Technologies Gmbto Enhance Global Offering of Interbody Spine Implants
Norderstedt, Germany – September 12, 2018 – Johnson & Johnson Medical Devices Companies*, through its subsidiary Johnson & Johnson Medical GmbH, announced today the acquisition of Emerging Implant Technologies Gmb(EIT), a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany. The in this portfolio leverage EIT’s proprietary advanced cellular titanium, which consists of an open and interconnected porous structure designed to allow bone to grow into the implant. As industry leaders across the full range of orthopaedic and spine specialties, Johnson & Johnson Medical Devices Companies will leverage its global commercial infrastructure to bring EIT’s technologies to patients around the world. 
New National Survey Uncovers the Surprising Impact that Knee and Hip Pain Has on Women’s Emotional Well-Being
WARSAW, Ind. – August 20, 2018 – While many who suffer from knee or hip pain know that it impacts their everyday activities, results from a new survey show the significant emotional impact of joint pain. This includes impact on romantic and social relationships, ability to pursue hobbies and overall mood. The survey of more than 500 women ages 45-65, including those who have had joint replacement surgery and those planning to have joint replacement surgery, revealed: 
Launches Expandable Interbody Implant as Part of a New Procedural Solution for Minimally Invasive Spine Surgery (MIS) that Enhances Surgical Efficiency
Raynham, – July 26, 2018 – Johnson & Johnson Medical Devices Companies* today announced 
that Synthes** is launching the Expandable Interbody Device in the 
The Implant is designed to treat patients suffering from degenerative disc disease as part of the new offering called (Transforaminal Lumbar Interbody Fusion) Procedural Solution. The complete system includes a comprehensive set of solutions to help simplify key stages of this surgery by enhancing surgical efficiency.
New Suture from Designed to Help Address Challenges Associated with Rotator Cuff Surgery
20, 2018 San Diego, – Johnson & Johnson Medical Devices Companies* through the Synthes** franchise today announces the launch of Suture to repair soft tissue such as the rotator cuff in the shoulder. Part of the Mitek Sports Medicine portfolio, Suture is available on Anchors and adds to Synthes’ innovative solutions designed to help address unmet patient needs in soft tissue repair. Suture was launched today at the San Diego Shoulder Institute’s 35th Annual Course. 
Healthcare Professionals
All inquiries can be submitted by email to:
Careers - Johnson & Johnson 
Consultant Identification & Payments
©2014-2018. All rights reserved. This site is published by Companies which is solely responsible for its content. This site is intended for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.
×Healthcare Professionals
Hospital Providers
Ambulatory Surgery Centers
Careers - Johnson & Johnson
(Craniomaxillofacial)
Joint Reconstruction (Knee, Hip & Shoulder)
Mitek Sports Medicine
What We Believe
Principles of Collaboration
Exhibits and Commercial Sponsorships
Investigator Initiated Research
Companies California Compliance
NOTICE: this information is provided pursuant to the requirements of Cal. Health & Safety Code § 119402 (1765), which requires certain pharmaceutical and medical device companies doing business in California to make available their program for compliance with applicable federal and state laws and industry standards regulating the marketing and promotion of their 
The Operating Companies of Synthes, under the legal entity Orthopaedics, Inc., (the "Company") have established a program designed to materially comply with applicable federal and state laws and industry standards relating to the marketing and promotion of its products. Additionally, the Company recognizes that adherence to these standards can be furthered through a compliance program that is informed by the Compliance Program Guidance for Pharmaceutical Manufacturers, published by the Office of Inspector General of the Department of Health and Human Services (the "Guide"). The Guide advises that effective compliance programs are comprised of seven elements. As described below, these elements form the basis of the Company's program for compliance with the standards regulating the marketing and promotion of its products.
 Overview of Compliance Program
1. Written Policies and Procedures
The Company has written policies to assure substantial compliance with the applicable laws and regulations and standards governing the marketing and promotion of our products. Among these standards are recognized industry codes of conduct including the Code of Ethics on Interactions with Health Care Professionals (AdvaMed Code), published by the Advanced Medical Technology Association ("AdvaMed"). The Company has established written policies that govern activities involving communicating with customers about the appropriate use of our including appropriate instruction, education, training, service and technical support required for the safe and effective use of our products. The Company also has policies governing activities involving the advancement of scientific and educational activities supporting medical research and education. These policies include:
Policies on Educational Grants and Research Grants
The Company may provide grants for specific educational purposes that benefit patients and customers. These may include, but are not limited to, continuing medical and paraprofessional education programs, fellowships provided to teaching institutions and similar organizations with a demonstrated commitment to scientific and technical education, and programs operated by organizations that provide high-quality, nationally recognized patient education. Funding of educational programs will generally be provided only to organizations and institutions and not to individual practitioners.
Research grants to support customer-initiated research may be provided for programs involving research in areas of legitimate interest to the company. All requests are subject to scientific review prior to funding approval.
Policy on Charitable Contributions and Patient Assistance
The Company will consider charitable contributions and requests for patient assistance in the areas of children's health, health care education, access to health care and community responsibility, consistent with the Company policies.
Policy on Travel Expense Reimbursement for CME, Promotional or Product Training Meetings
The Company will, with very limited exceptions that are in accordance with nationally recognized standards, not reimburse for travel and lodging expenses of attendees at promotional and educational programs.
The Company may reimburse attendees for their reasonable travel and lodging expenses associated with attendance at product training meetings. Product training meetings will be conducted in locations conducive to the exchange of information such as educational or conference settings. Where face-to-face or hands-on customer training is reasonably necessary for the safe and effective use of the Company's medical device is required, the Company may provide training at company facilities, at independent teaching centers such as medical institutions, or in other appropriate clinical settings.
Policy on Business Meals
The Company may occasionally offer a modest meal, consistent with the standards of the AdvaMed Code as part of an educational presentation or a business discussion. Venues that feature entertainment or recreation, and attendance by spouses or guests, are not permitted.
Policy on the Provision of Educational and Practice-Related Items
On occasion, the Company representatives may provide items that benefit patients or serve a genuine educational function for Health Care Professionals, consistent with the standards of the AdvaMed Code.
Total Annual Dollar Limit for Meals and Educational or Practice-related Items 
Each of the Companies, have established an annual limit of $1,500 for meals and educational items as the aggregate value of the items or activities that may be provided to California health care professionals pursuant to the requirements of Cal. Health & Safety Code § 119402 (1765).
It is the policy of the Company not to provide Entertainment (e.g. sporting events, golf outings, concerts, hunting, etc.) to customers.
The Company has appointed Health Care Compliance Officers. Our Health Care Compliance Officers have been empowered with appropriate authority to exercise independent judgment and has free and unencumbered access to senior management.
The Company has appointed Health Care Compliance Committees. The committees are comprised of the Company's Health Care Compliance Officers and members of the Company's management team.
The Company has an annual Health Care Compliance training process that includes testing and annual certification of appropriate employees. The training covers applicable guidelines governing our compliance program. Employees are also trained on the consequences of failure to comply with the requirements of the company's compliance program.
The Company encourages open and candid discussion between management and employees regarding any compliance concerns. The Company employees are encouraged to report their concerns to their manager, to the Human Resources Department, to the Law Department or to the company's Health Care Compliance Officer.
The Company self-assesses and periodically audits its compliance with its policies and procedures.
The Company will take disciplinary actions in response to violation of the company's compliance policies or procedures. The Company will conduct a fair and diligent investigation of matters that are brought to the company's attention in order to ensure the consistent application of the company's standards.
7. Responses To Detected Problems and Actions To Correct Issues.
The Company requires a prompt and diligent response to potential violations of the company's compliance program, including its standards regulating the marketing and promotion of our products. Actions in response to detected problems may include improving policies, procedures, training, communication and monitoring or may require disciplinary action to prevent future violations.
For a copy of this California Compliance Program, please call 1-877-889-3636. Provide your name, mailing address and request that a copy of the California Compliance program be sent to you.
As part of the Company's ongoing efforts in the area of compliance, we have developed a Comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. To our knowledge as of the date of this declaration, the Company is in compliance with our Comprehensive Compliance Program, as described here, and with California Health & Safety Code sections 119400-119402.
Careers - Johnson & Johnson 
Consultant Identification & Payments
©2014-2018. All rights reserved. This site is published by Companies which is solely responsible for its content. This site is intended for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.
